dronabinol has been researched along with Carcinoma, Ovarian Epithelial in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Anil, SM; Belausov, E; Kendall, M; Koltai, H; Kumar, N; Peeri, H; Shalev, N; Tiwari, S; Vinayaka, AC | 1 |
1 other study(ies) available for dronabinol and Carcinoma, Ovarian Epithelial
Article | Year |
---|---|
Phytocannabinoid Compositions from Cannabis Act Synergistically with PARP1 Inhibitor against Ovarian Cancer Cells In Vitro and Affect the Wnt Signaling Pathway.
Topics: Cannabinoid Receptor Agonists; Cannabis; Carcinoma, Ovarian Epithelial; Dronabinol; Female; Hallucinogens; Humans; Ovarian Neoplasms; Poly (ADP-Ribose) Polymerase-1; Wnt Signaling Pathway | 2022 |